Evidence map›Paper›PMID 26690252›Full record

ReviewWorld journal of gastrointestinal oncology2015

Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives.

Alberto Biondi, Maria C Lirosi, Domenico D'Ugo, Valeria Fico, Riccardo Ricci, Francesco Santullo, Antonia Rizzuto, Ferdinando Cm Cananzi, Roberto Persiani

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in World journal of gastrointestinal oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07183358 (Effect of Family-Supervised Multimodal Prehabilitation Throughout Preoperative Neoadjuvant Chemotherapy on Clinical Outcomes in Gastric Cancer Patients), which is not on this map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07183358 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Effect of Family-Supervised Multimodal Prehabilitation Throughout Preoperative Neoadjuvant Chemotherapy on Clinical Outcomes in Gastric Cancer Patients: A Single-Center Randomized Controlled Trial

TypeinterventionalSponsorThe Affiliated Hospital of Qingdao UniversityRan2025 to 2026Enrolled90ConditionsStomach Neoplasms, Neoadjuvant TherapyArmsFamily-supervised Multimodal Prehabilitation, Standard Care
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Oral nutrition interventions in patients undergoing gastrointestinal surgery for cancer: A systematic literature review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Novel Tumor-Targeting Nanoparticles for Cancer Treatment-A Review.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alberto BiondiAlberto Biondi, Maria C Lirosi, Domenico D'Ugo, Valeria Fico, Francesco Santullo, Roberto Persiani, General Surgery Unit, Department of Surgery, "A. Gemelli" University Hospital Catholic University of Rome, 00168 Rome, Italy.
Maria C LirosiAlberto Biondi, Maria C Lirosi, Domenico D'Ugo, Valeria Fico, Francesco Santullo, Roberto Persiani, General Surgery Unit, Department of Surgery, "A. Gemelli" University Hospital Catholic University of Rome, 00168 Rome, Italy.
Domenico D'UgoAlberto Biondi, Maria C Lirosi, Domenico D'Ugo, Valeria Fico, Francesco Santullo, Roberto Persiani, General Surgery Unit, Department of Surgery, "A. Gemelli" University Hospital Catholic University of Rome, 00168 Rome, Italy.
Valeria FicoAlberto Biondi, Maria C Lirosi, Domenico D'Ugo, Valeria Fico, Francesco Santullo, Roberto Persiani, General Surgery Unit, Department of Surgery, "A. Gemelli" University Hospital Catholic University of Rome, 00168 Rome, Italy.
Riccardo RicciAlberto Biondi, Maria C Lirosi, Domenico D'Ugo, Valeria Fico, Francesco Santullo, Roberto Persiani, General Surgery Unit, Department of Surgery, "A. Gemelli" University Hospital Catholic University of Rome, 00168 Rome, Italy.
Francesco SantulloAlberto Biondi, Maria C Lirosi, Domenico D'Ugo, Valeria Fico, Francesco Santullo, Roberto Persiani, General Surgery Unit, Department of Surgery, "A. Gemelli" University Hospital Catholic University of Rome, 00168 Rome, Italy.
Antonia RizzutoAlberto Biondi, Maria C Lirosi, Domenico D'Ugo, Valeria Fico, Francesco Santullo, Roberto Persiani, General Surgery Unit, Department of Surgery, "A. Gemelli" University Hospital Catholic University of Rome, 00168 Rome, Italy.
Ferdinando Cm CananziAlberto Biondi, Maria C Lirosi, Domenico D'Ugo, Valeria Fico, Francesco Santullo, Roberto Persiani, General Surgery Unit, Department of Surgery, "A. Gemelli" University Hospital Catholic University of Rome, 00168 Rome, Italy.
Roberto PersianiAlberto Biondi, Maria C Lirosi, Domenico D'Ugo, Valeria Fico, Francesco Santullo, Roberto Persiani, General Surgery Unit, Department of Surgery, "A. Gemelli" University Hospital Catholic University of Rome, 00168 Rome, Italy.
Agostino Gemelli University Polyclinic · ITMagna Graecia University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last 20 years, several clinical trials on neoadjuvant chemotherapy and chemo-radiotherapy as a therapeutic approach for locally advanced gastric cancer have been performed. Even if more data are necessary to define the roles of these approaches, the results of preoperative treatments in the combined treatment of gastric adenocarcinoma are encouraging because this approach has led to a higher rate of curative surgical resection. Owing to the results of most recent randomized phase III studies, neoadjuvant chemotherapy for locally advanced resectable gastric cancer has satisfied the determination of level I evidence. Remaining concerns pertain to the choice of the optimal therapy regimen, strict patient selection by accurate pre-operative staging, standardization of surgical procedures, and valid criteria for response evaluation. New well-designed trials will be necessary to find the best therapeutic approach in pre-operative settings and the best way to combine old-generation chemotherapeutic drugs with new-generation molecules.

Indexed as

ChemotherapyGastric CancerNeo-adjuvant treatmentRadiotherapy

Identifiers

PMID26690252
PMCPMC4678386
OpenAlexW2206146039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.